HLC‑M‑1004 expands the HLC™ Adhesives portfolio, which utilizes a hybrid light‑curable platform to support curing in both light‑exposed and shadowed areas. The adhesive combines on‑contact cure in dark areas with rapid, low‑intensity UV or visible‑light curing to support fast, reliable manufacturing.
Designed for medical device assembly, HLC-M-1004 is well-suited for applications involving catheters, diagnostic and therapeutic devices, and other parts that incorporate opaque or light-blocking substrates. The adhesive delivers low viscosity for controlled dispensing and penetration into tight bond gaps, enabling consistent bond formation without the need for primers.
Additional performance benefits include limited blooming with proper light curing, flexibility after cure, and improved aesthetics. The material provides rapid fixturing to support high-throughput manufacturing processes.
HLC-M-1004 has been evaluated in accordance with applicable ISO 10993 biocompatibility standards and contains no nonreactive solvents. As a one-part material, it helps manufacturers simplify processes, reduce waste, and improve overall production efficiency.
With the addition of HLC-M-1004, Dymax continues to expand the HLC Adhesive family to address evolving bonding challenges in medical device assembly environments.
For additional information on Dymax, visit www.dymax.com
Dymax develops innovative rapid and light-curable materials, dispensing equipment, and UV/LED light-curing systems. The company’s adhesives, coatings, and equipment are perfectly matched to work seamlessly with each other, providing design engineers with tools to dramatically improve manufacturing efficiencies. Major markets include aerospace and defense; medical device; and consumer and automotive electronics.
DYMAX Europe GmbH
Kasteler Straße 45
65203 Wiesbaden
Telefon: +49 (611) 962-7900
Telefax: +49 (611) 962-9440
https://de.dymax.com/
Marketing Communications Specialist EMEA
Telefon: 00496119627909
